Searched for
SURYA PHARMA
Nifty IT bottoming out? Anand James on the expiry outlook, pharma profit-booking, and 2 stocks to buy this weekGeojit Investments’ Anand James expects Nifty to attempt a range breakout above 23,700 during the monthly expiry week. He highlighted early...- Decide on Piramal's Dahej plant in a week: Supreme Court to Gujarat Pollution Control BoardThe Supreme Court has issued a swift order for the Gujarat Pollution Control Board to review Piramal Pharma's appeal to reactivate its Dahe...
- Landmark Cars, Force Motors among 8 BSE small cap stocks surge to new 52-week highsSeveral BSE Smallcap stocks reached their 52-week high and generated market excitement. AstraZeneca Pharma, Apar Industries, Force Motors, ...
- Surya Pharma CDR fails; bankers to start recovery processAccording to sources with direct knowledge of the development, the company's promoters failed to bring the required Rs 85 crore for the deb...
- Surya Pharma launches neuropsychiatric divisionThe Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .
- Surya Healthcare Buys MedimartPharma retail chain Surya Healthcare has bought Hyderabad-based Medimart Pharmacy , which runs 42 drug retail outlets in Andhra Pradesh, fo...
- Midcap mantra: US buy to strain Surya's cash flowSurya Pharmaceuticals has entered the over-the-counter (OTC) segment in healthcare with the acquisition of US brands.
- Surya Pharma arm buys US-based ActivOn for USD 22 mnChandigarh-based Surya Pharmaceuticals today said its subsidiary has acquired US-based over-the-counter analgesic drug manufacturer ActivOn...
- Decent returns expected from Biocon: Shrikant Chouhan"We can expect further appreciation and we may expect rally of next 3 to 4 months and decent returns are always there."
- Lupin, Cadila, Strides Arcolab, Ipca Laboratories and Biocon are good bets: Ashit SuriIn pharma space, big players like Lupin and Cadila have been very consistent in the performances.
- Ind-Swift Labs in strong uptrend: Deepak MohoniSecond-rung pharmas are not only creating high volumes right now but are also in pretty strong uptrends and that is where this Ind-Swift La...
- Target of 300-plus for Surya Pharma: Ashit SuriThis is a company which has a turnover of around Rs 1130 crore, and has not really been in the limelight all this while in spite of its stu...
- Heard on the street: Order in pipeline boosts Precision PipesThe Precision Pipes & Profiles stock ended firm on Thursday on rumours that the company is close to getting a sizeable order from a multina...
- Crocs to focus on medical footwear; ties up with Surya PharmaUS-based premium footwear brand Crocs Inc today said it is targeting the country's market for its specialised range of medical footwear and...
- Surya Pharma ties up with US-based Crocs for medical footwearSurya Pharmaceutical today said it has entered into an exclusive marketing tie-up with the US-based footwear maker Crocs for selling the la...
- Index may breakout above 5300-5330 over the next five trading sessions: Devang VisariaDevang Visaria, Chief Strategist, devangvisaria.com in a chat with ET Now talks about the trend of the index.
- Take a long bet on Sun Pharma with a stop close to 1708: Devang VisariaDevang Visaria, Chief Strategist, devangvisaria.com in a chat with ET Now talks about pharmaceuticals stocks.
- Surya Pharma to foray into education sectorSurya Pharmaceuticals Limited is planning to foray into the education sector by setting up an integrated educational campus in Punjab, at a...
- Atlas Cycles, Shanku lead charge into pharma sectorThe pharmaceutical sector-an area largely insulated from the downturn-is attracting companies from other sectors.
- New excise regime may take sheen off outsourcing dealsThe new excise duty regime for pharmaceuticals is expected to trigger a shift in the outsourcing business, touted as a big opportunity for ...
Load More
